NCT00521781 - Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

October 31, 2008

Conditions

Prostatic Neoplasms

Interventions

DRUG

Abraxane

100 mg/m2 IVPB Day 1, 8, 15, 22, 29,36,43,50 of each cycle for 4 nine-week cycles (Each cycle of Abraxane/hormonal therapy will consist of 8 weeks of Abraxane therapy and 1 week of rest.)

DRUG

Leuprolide

7.5 mg monthly or 22.5 mg quarterly, can begin within 3 months of initiating Abraxane for 2 years

DRUG

Bicalutamide

50 mg p.o. daily starts week 36 of initiating Abraxane.

Trial Locations (1)

77030

Baylor College of Medicine - Methodist Hospital, Houston